Semaglutide 3 mg, 7 mg and 14 mg Tablets in India for Better Diabetes Control

91 8750275027 l.w
1 / 1
Embed
Share

Semaglutide 3 mg, 7 mg, and 14 mg tablets are a groundbreaking treatment for Type 2 diabetes, offering exceptional blood sugar control and cardiovascular benefits. Designed to improve glycemic management and promote weight reduction, Semaglutide 3 mg


Uploaded on | 0 Views


Download Presentation

Please find below an Image/Link to download the presentation.

The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author. Download presentation by click this link. If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.

E N D

Presentation Transcript


  1. (+91) 8750275027 contact@impomedhealthcare.com C-70, SECOND FLOOR OFFICE -A, DDA SHEDS, OKHLA INDUSTRIAL AREA, PHASE- 1, NEW DELHI-110020. Home Who We Are What We Do Diseases Treatment FAQs Contact Us SEMAGLUTIDE Home | Miscellaneous | Antivirals | SEMAGLUTIDE SEMAGLUTIDE Tablets Description Composition Dosage Indications Contact Us SEMAGLUTIDE 3 MG, 7 MG AND 14 MG TABLETS RYBELSUS (semaglutide) tablets, for oral use. C-70, SECOND FLOOR OFFICE -A, DDA SHEDS, OKHLA INDUSTRIAL AREA, PHASE- 1, NEW DELHI-110020. +91-9007090388 +91-8750275027 contact@impomedhealthcare.com rahman@impomedhealthcare.com mohan.singh@impomendhealthcare.com Quick Links Diseases Corporate O?ce Home Who We Are What We Do Treatment FAQs Contact Us Blog Cancer Neurology Endocrinology Miscellaneous C-70, SECOND FLOOR OFFICE -A, DDA SHEDS, OKHLA INDUSTRIAL AREA, PHASE- 1, NEW DELHI-110020. , +91-8750275027 +91-9007090388 Established in New Delhi, India in 2020, ImpoMed Healthcare has grown over the years from a new start up to one of the Most Preferred Company for Facilitation of the USFDA/European FDA Approved. contact@impomedhealthcare.com rahman@impomedhealthcare.com Imported Drugs-Only mohan.singh@impomendhealthcare.com Follow us on: Copyright 2024 ImpoMed

Related


More Related Content